Fecal microbial biomarkers

Biomarker

1 paper2 findings

Effects

2

Advanced-neoplasia sensitivity

downin humans1

1 study
  1. Fecal microbial biomarkers decrease advanced-neoplasia sensitivity in humans (21.8% to 17.5%).

    “sensitivity decreased from 21.8% to 17.5%”

    Reviewin specificity-oriented triage

    Incremental Diagnostic Value of Fecal Microbial Biomarkers Added to Quantitative Fecal Immunochemical Testing for Colorectal Neoplasia: A Systematic Review

    Research Square29 Aug 2026Preprint

More on Advanced-neoplasia sensitivity

ACN sensitivity

upin humans1

1 study
  1. Fecal microbial biomarkers increase ACN sensitivity in humans (+10.0 percentage points, 95% CI 6.3–13.7).

    “M3 plus FIT increased ACN sensitivity by 10.0 percentage points (95% CI 6.3–13.7; p<0.001)”

    Reviewas sensitivity-oriented add-on strategy to qFIT

    Incremental Diagnostic Value of Fecal Microbial Biomarkers Added to Quantitative Fecal Immunochemical Testing for Colorectal Neoplasia: A Systematic Review

    Research Square29 Aug 2026Preprint

More on ACN sensitivity

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months